- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1757EUR$2,000USD£1,516GBP
- Clinical Trials
- April 2025
- 280 Pages
Global
From €2636EUR$3,000USD£2,274GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1318EUR$1,500USD£1,137GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1318EUR$1,500USD£1,137GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1318EUR$1,500USD£1,137GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1098EUR$1,250USD£947GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1098EUR$1,250USD£947GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1098EUR$1,250USD£947GBP
- Report
- June 2025
- 150 Pages
Global
From €2372EUR$2,699USD£2,046GBP
- Report
- June 2025
- 200 Pages
Global
From €2451EUR$2,789USD£2,114GBP
- Report
- June 2025
- 150 Pages
Global
From €2372EUR$2,699USD£2,046GBP
- Report
- June 2025
- 400 Pages
Global
From €4349EUR$4,949USD£3,751GBP
- Report
- July 2024
- 48 Pages
Global
From €3510EUR$3,995USD£3,028GBP
- Report
- June 2025
- 245 Pages
Global
From €4389EUR$4,995USD£3,786GBP
- Report
- March 2024
- 150 Pages
Global
From €5228EUR$5,950USD£4,510GBP
- Report
- December 2022
- 100 Pages
Global
From €5228EUR$5,950USD£4,510GBP
- Report
- August 2023
- 150 Pages
Global
From €5228EUR$5,950USD£4,510GBP
- Report
- February 2023
- 260 Pages
Global
From €2460EUR$2,800USD£2,122GBP
- Report
- September 2021
- 40 Pages
China
From €2285EUR$2,600USD£1,971GBP
- Report
- May 2024
- 128 Pages
Global
From €5710EUR$6,499USD£4,926GBP

Serotonin is a neurotransmitter found in the central nervous system (CNS) that plays a role in regulating mood, appetite, sleep, and other bodily functions. It is a key target for drugs used to treat depression, anxiety, and other mental health disorders. Serotonin-based drugs are typically selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). These drugs work by blocking the reuptake of serotonin, allowing it to remain active in the brain for longer periods of time.
The serotonin market is a subset of the larger CNS drug market, which is estimated to be worth billions of dollars. It is a highly competitive market, with many large pharmaceutical companies vying for market share. Companies in the serotonin market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more